The FDA is seeking feedback on a list of patient preference areas that it put together to help them take into account patients’ views as they make regulatory decisions about medical devices. Included on this list of patient preference areas is “Ear, Nose, and Throat: Treatments for moderate to severe hearing loss (implanted hearing devices vs. other treatment options).”
The FDA is seeking information or qualitative or quantitative assessments of whether patients prefer certain alternatives, outcomes or choices over others in terms of their health.
The FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risks and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Check out their request for comments on the Federal Register.
Recent Posts
Senate Passes Continuing Resolution: What It Means for Hearing Health
The Senate recently passed a continuing resolution (CR) to keep the federal government funded through December 11, 2026, giving Congress additional time to complete the…
General Audiology Board Certification (GABC): Historical, Current and Future Perspectives and Why It Matters
Like many other healthcare professionals, audiologists have the dubious distinction of the “alphabet signature” indicating our training and education, our expertise, and commitment to our…



